![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10813 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-phospho-PKC beta 1/2(Thr500) |
克隆性 | |
靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
宿主 | 詳見(jiàn)說(shuō)明書(shū) |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PKC beta around the phosphorylation site of (Thr500) |
中文名稱(chēng) 磷酸化蛋白激酶C β1/β2(Thr500)抗體費(fèi)用
英文名稱(chēng) Anti-phospho-PKC beta 1/2(Thr500)
別 名 MGC41878; PKC B; PKC beta; PKCB; PKCB1; PKCB2; PKCbeta; PRKCB 1; PRKCB 2; PRKCB; PRKCB I; PRKCB II; PRKCB1; PRKCB2; Protein kinase C beta 1; Protein kinase C beta 1; Protein kinase C beta 2; Protein kinase C beta; Protein kinase C beta type; KPCB_HUMAN.
產(chǎn)品屬性:
磷酸化蛋白激酶C β1/β2(Thr500)抗體費(fèi)用 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 1ml/1mg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類(lèi)型 一抗 磷酸化抗體
研究領(lǐng)域 細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 81kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PKC beta around the phosphorylation site of (Thr500)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化蛋白激酶C β1/β2(Thr500)抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Protein kinase C (PKC) is a calcium-activated, phospholipid-dependent, serine- and threonine-specific enzyme. PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters.
Protein Kinase C beta (PKC beta) is an 80 kDa member of the conventional group (cPKCs: sensitive to diacylglycerol, phosphotidylserine and phorbol esters) of the PKC family of serine/threonine kinases that are involved in a wide range of physiological processes including mitogenesis, cell survival, transcriptional regulation and tumor promotion. PKC beta has been implicated in diabetes and carcinogenesis. PKC beta isoforms 1 & 2 are phosphorylated on three sites, threonine 500 in the activation loop, beta 1 threonine 642 (beta 2 641) in the turn loop and beta 1 serine 661 (beta 2 660) in the hydrophobic loop. Phosphorylation of PKC beta 1 & 2 on threonine 500 by PDK1 is a prerequisite for its autophosphoylation and catalytic competence.
Function : Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity. Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. May participate in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity).
Subunit : Interacts with PDK1 (By similarity). Interacts in vitro with PRKCBP1. Interacts with PHLPP1 and PHLPP2; both proteins mediate its dephosphorylation. Interacts with KDM1A/LSD1, PKN1 and ANDR.
Post-translational modifications : Phosphorylation on Thr-500 within the activation loop renders it competent to autophosphorylate. Subsequent autophosphorylation of Thr-642 maintains catalytic competence, and autophosphorylation on Ser-661 appears to release the kinase into the cytosol. Autophosphorylation on other sites i.e. in the N-terminal and hinge regions have no effect on enzyme activity. Phosphorylation at Tyr-662 by SYK induces binding with GRB2 and contributes to the activation of MAPK/ERK signaling cascade (By similarity).
Similarity : Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
Contains 1 AGC-kinase C-terminal domain.
Contains 1 C2 domain.
Contains 2 phorbol-ester/DAG-type zinc fingers.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: P05771.4
實(shí)驗(yàn)流程:
全、新、優(yōu)、品、好四大特點(diǎn):
磷酸化蛋白激酶C β1/β2(Thr500)抗體費(fèi)用 全:公司提供上萬(wàn)種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢(xún)。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
技術(shù)外包服務(wù):
★磷酸化蛋白激酶C β1/β2(Thr500)抗體費(fèi)用 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷(xiāo)的相關(guān)產(chǎn)品:
Human Complement fragment 5a,C5a ELISA Kit 人補(bǔ)體片斷5aMulti-class antibodies規(guī)格: 48T
Anti-Phospho-Rictor (Thr1135) 磷酸化雷帕霉素靶蛋白復(fù)合體2抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh GTDC1 糖基轉(zhuǎn)移酶樣1抗體 規(guī)格 0.2ml
SP ELISA Kit 大鼠P物質(zhì) 96T
Omgp 英文名稱(chēng): 少突細(xì)胞髓磷脂糖蛋白抗體 0.1ml
BPGM 英文名稱(chēng): 紅細(xì)胞2,3 - 二磷酸甘油酸合成酶抗體 0.2ml
Anti-Phospho-Rictor (Thr1135) 磷酸化雷帕霉素靶蛋白復(fù)合體2抗體Multi-class antibodies規(guī)格: 0.1ml
Anti-MMP-12/FITC 熒光素標(biāo)記基質(zhì)金屬蛋白酶-12/巨噬細(xì)胞金屬?gòu)椓Φ鞍酌缚贵wIgGMulti-class antibodies規(guī)格: 0.2ml
Anti-TSARG7/FITC 熒光素標(biāo)記發(fā)生相關(guān)的新基因抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh AARE 氧化蛋白質(zhì)水解酶 規(guī)格 0.2ml
Mouse Anti-Bov IgG/PE-Cy5.5 PE-Cy5.5標(biāo)記的小鼠抗IgG 0.1ml
GABABRBP 英文名稱(chēng): G基B型受體結(jié)合蛋白抗體 0.2ml
Rhesus antibody Rh PUS10/CCDC139 卷曲螺旋結(jié)構(gòu)域蛋白139抗體 規(guī)格 0.2ml
Anti-TSARG7/FITC 熒光素標(biāo)記發(fā)生相關(guān)的新基因抗體IgGMulti-class antibodies規(guī)格: 0.2ml
IL-23 小鼠白介素-23Multi-class antibodies規(guī)格: 48T
Anti-Eph receptor B2/Ephb2 Ephb2抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh MTCH2 線粒體載體同源蛋白2抗體 規(guī)格 0.2ml
ECP(Human eosinophil cationic protein) ELISA Kit 人嗜酸性粒細(xì)胞陽(yáng)離子蛋白 96T
SIT 英文名稱(chēng): 跨膜接頭蛋白SIT抗體 0.1ml
IL2RA 英文名稱(chēng): 白介素2受體a鏈/IL-2RA抗體 0.1ml
Anti-Eph receptor B2/Ephb2 Ephb2抗體Multi-class antibodies規(guī)格: 0.1ml
龍膽紫血液瓊脂基礎(chǔ)250g用于桿菌的選擇性培養(yǎng)
DEV Lactose broth DEV乳糖肉湯 1.10689.0500 MERCK默克 incubation media DEV Lactose broth DEV乳糖肉湯 1.10689.0500 MERCK默克
改良月桂基鹽胰蛋白胨肉湯(MLST) 250g 用于奶粉中阪崎腸桿菌的檢驗(yàn)的增菌和分子生物學(xué)檢驗(yàn)方法(PCR)選擇性增菌(GB 4789.40-2010和SN1...
臍帶間質(zhì)干細(xì)胞成脂誘導(dǎo)分化培養(yǎng)基Umbilicalcordmesenchymalstemcellsintotheculturemediuminduceddifferentiationoffat
MFB培養(yǎng)基 250g 用于李斯特氏菌的選擇性增菌培養(yǎng)
品紅亞培養(yǎng)基(遠(yuǎn)藤瓊脂培養(yǎng)基)2250g用于水中大腸菌群的分離或確證試驗(yàn)。
麥芽浸膏瓊脂 (CM0059) Oxoid incubation media 麥芽浸膏瓊脂 (CM0059) Oxoid
擬青霉 支/瓶
改良EC肉湯(mEC+n)250g用于0性增菌(GB標(biāo)準(zhǔn))
MannitolSaltAgarMedium
磷酸化蛋白激酶C β1/β2(Thr500)抗體費(fèi)用 錳鹽營(yíng)養(yǎng)瓊脂 規(guī)格: 250g 用途: 用于嗜溫和嗜熱需氧芽孢桿菌的檢測(cè)
酸性肉湯 規(guī)格: 250g 用途: 用于酸性罐頭食品商業(yè)無(wú)菌檢驗(yàn)
溴紫葡萄糖肉湯 規(guī)格: 250g 用途: 用于低酸性罐頭食品商業(yè)無(wú)菌檢驗(yàn)
血平板 (成品培養(yǎng)基) 規(guī)格: 20個(gè)/盒 用途: 用于營(yíng)養(yǎng)要求較高的細(xì)菌的培養(yǎng)及溶血試驗(yàn)